Pay in 4 interest-free payments of $5.25 Learn more
Ships within 48 hours · Estimated delivery Sep 2 - Sep 7
A GSL Switch is Unlikely in the Current Climate Despite a recent drive by the Department of Health and Social Care (DHSC) to encourage the reclassification of certain medicines (like those for pain, sleep aids, and skin conditions) to P or GSL status, a switch for injectable B12 is not on the cards
If tolerance is good and no concerning reactions occur, consider increasing to twice-daily application or moving to a 1 percent concentration
BPC-157 affects hemostasis in complex ways, reducing both thrombosis risk and bleeding complications in animal studies
FDA nonclinical toxicology review (2023-2024) flagged DNA damage in pituitary cells and injection-site necrosis in animal studies, plus immunogenicity and impurity risks from compounded material, alongside GH/IGF-1-axis effects such as fluid retention, joint discomfort, flushing, and headache reported by users
Can I use MIC B12 if I'm also considering GLP-1 peptide therapy
US$ 23.69
US$ 29.79
US$ 22.54
US$ 20.21
US$ 22.61
US$ 27.67
US$ 28.74
US$ 26.09
US$ 26.49
US$ 26.79
US$ 20.80
US$ 22.69
